LAUSR

Oncken), University of Connecticut School of Medicine; and the Department of Internal Medicine (Dr Bastian) and VA Connecticut Healthcare System, Yale School of Medicine. FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: C. O. reports ongoing National Institutes of Health (NIH) funding [Grant 5R01HD069314] for a clinical trial examining the efficacy of the nicotine inhaler for smoking cessation in pregnant women. Pfizer Pharmaceuticals has provided free nicotine and placebo inhaler product for this study. None declared (M. F. P., L. A. B.). CORRESPONDENCE TO: Mario F. Perez, MD, MPH, Department of Medicine, University of Connecticut School of Medicine, 263 Farmington Ave, Farmington, CT 06030; e-mail: [email protected] Copyright 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. DOI: http://dx.doi.org/10.1016/j.chest.2017.03.029 problem even among smokers who are trying to quit. Smoking cessation treatment must be integrated into specialty care, especially in respiratory therapy clinics.